MYAH- A Powerful Tool for Dry Eye and Myopia Management
Komoka Optometry is excited to introduce our new instrument which duals as a diagnostic device for dry eye assessment and myopia management. The MYAH by Topcon Healthcare allows us to generate data for diagnosing, managing and educating patients on dry eye and myopia, conditions which are seeing increased prevalence and attention.
Dry Eye Assessment
The MYAH includes a comprehensive suite of dry eye assessment tools to help support patient education and treatment recommendations. Tear film quality can be non-invasively assessed through measuring the speed of tear evaporation (called tear break-up time or TBT) as well as measuring the tear volume along the bottom lid (called tear meniscus height or TMH). Infrared technology also allows the MYAH to image the oil glands along the top and bottom lids called Meibomian glands. The percent of gland loss can then be calculated for a selected area.
The results of these assessments can be visualized in a report summarizing the tear quality and gland loss as seen below. The results can be used to support treatment recommendations for dry eye disease.
The MYAH further aids in managing myopia in children by taking axial length measurements- the length of the eye from front to back. The progression of myopia or nearsightedness can be slowed down with special technology in glasses or contact lenses. Analyzing the changes in a child’s axial length over time allows us to determine whether they would be a good candidate for the Brilliant Future’s myopia management program. We can then track how the axial length and prescription change over time when monitoring the effectiveness of the myopia intervention.
In addition to the dry eye suite and myopia management features, the MYAH is also capable of measuring corneal topography with 3D and height maps to screen for keratoconus. Fluorescein simulation further allows for accurate RGP lens fitting while pupillometry can be measured under different light levels, which is useful for multifocal lenses and after refractive surgery.
Educating patients is key when managing conditions such as myopia and dry eye disease. The MYAH provides our patients with quantitative data to support diagnosis and treatment recommendations. In the age of COVID-19, prolonged screen time is a reality for many adults and children. Increased exposure to digital screens for near-work is a risk factor for the progression of both myopia and dry eye disease. The MYAH is suited to manage these prevailing conditions and their implications on ocular health and quality of life.
Call us at 519-473-3937 to schedule a dry eye consultation or to learn more about the Brilliant Future’s myopia management program.